Immunity against poliomyelitis in the Netherlands, assessed in 2006 to 2007: The importance of completing a vaccination series

Eurosurveillance

Volumn 19, Issue 7, 2014, Pages

  Van der Maas, N A ^a   Mollema, L ^a   Berbers, G A ^a   Van Rooijen, D M ^a   Van der Avoort, H G ^a   Conyn Van Spaendonck, M A E ^a   de Melker, H E ^a   Van der Klis, F R ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; POLIOMYELITIS; QUESTIONNAIRE; RISK FACTOR; SERODIAGNOSIS; SEROPREVALENCE; VACCINATION; VIRUS NEUTRALIZATION;

EID: 84894261773     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.7.20705     Document Type: Article

References (39)

1. Huisman J, editor. Immunisatie tegen infectieziekten. [Immunisation against infectious diseases]. Alphen aan de Rijn/Brussel: Stafleu; 1984. Dutch.
2. Forty-first Wolrd Health Assembly. Resolutions and decisions. WHA41.28. Global eradication of poliomyelitis by the year 2000. Geneva: World Health Organization; 1988. Available from: http://www.polioeradication.org/Portals/0/Document/AboutUs/History/WHA.Resolutions.and.Decisions.pdf
3. Van Vliet H. Geschiedenis Van de meldingsplicht. [History of notification]. Tijdschrift voor infectieziekten. 2009;4(2):51-60. Dutch. Available from: http://www.ariez.nl/DownloadFile.lynkx?guid=b8ffbdc3-fbe0-4d1f-a0ac-90a6b3c73c7d
4. Bijkerk H. Poliomyelitis epidemic in the Netherlands, 1978. Dev Biol Stand. 1979;43:195-206.
5. Bijkerk H, Draaisma FJ, Landheer T, Van Os M. [Poliomyelitis epidemic in Staphorst]. Ned Tijdschr Geneeskd. 1972;116(14):549-558. Dutch.
6. Oostvogel PM, Van Wijngaarden JK, Van der Avoort HG, Mulders MN, Conyn-Van Spaendonck MA, Rumke HC, et al. Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992-93. Lancet. 1994;344(8923):665-670. http://dx.doi.org/10.1016/S0140-6736(94)92091-5
7. Bijkerk H, Draaisma FJ, Van der Gugten AC, Van Os M. [The poliomyelitis epidemic in 1978]. Ned Tijdschr Geneeskd. 1979;123(39):1700-1714. Dutch.
8. Rümke HC, Oostvogel PM, Van Steenis G, Van Loon AM. Poliomyelitis in The Netherlands: a review of population immunity and exposure between the epidemics in 1978 and 1992. Epidemiol Infect. 1995;115(2):289-298. http://dx.doi.org/10.1017/S0950268800058416
9. Schaap GJ, Bijkerk H, Coutinho RA, Kapsenberg JG, van Wezel AL. The spread of wild poliovirus in the well-vaccinated Netherlands in connection with the 1978 epidemic. Prog Med Virol. 1984;29:124-140.
10. Centers for Disease Control and Prevention (CDC). Isolation of wild poliovirus type 3 among members of a religious community objecting to vaccination--Alberta, Canada, 1993. MMWR Morb Mortal Wkly Rep. 1993;42(17):337-339.
11. Conyn-van Spaendonck MA, Oostvogel PM, van Loon AM, van Wijngaarden JK, Kromhout D. Circulation of poliovirus during the poliomyelitis outbreak in The Netherlands in 1992-1993. Am J Epidemiol. 1996;143(9):929-935. http://dx.doi.org/10.1093/oxfordjournals.aje.a008836
12. Anis E, Kopel E, Singer SR, Kaliner E, Moerman L, Moran-Gilad J, et al. Insidious reintroduction of wild poliovirus into Israel, 2013. Euro Surveill. 2013;18(38):pii: 20586
13. World Health Organization (WHO). Polio in the Syrian Arab Republic - update. Geneva: WHO; 2013. Available from: http://www.who.int/csr/don/2013_11_11polio/en/
14. de Melker HE, Schellekens JF, Neppelenbroek SE, Mooi FR, Rumke HC, Conyn-van Spaendonck MA. Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis. 2000;6(4):348-357. http://dx.doi.org/10.3201/eid0604.000404
15. Gezondheidsraad. Vaccinatie tegen kinkhoest. [Vaccination against pertussis]. Den Haag: Gezondheidsraad; 2004. Dutch. Available from: http://www.gezondheidsraad.nl/sites/default/files/0404nadden.pdf
16. Van Lier A. Vaccinatiegraad Rijksvaccinatieprogramma Nederland; Verslagjaar 2011. [Vaccination coverage National Immunisation Programme of the Netherlands; year of report 2011]. Bilthoven: National Institute for Public Health and the Environment; 2011. Dutch. Available from: http://www.rivm.nl/dsresource?objectid=rivmp:47976&type=org&disposition=inline&ns_nc=1
17. De Melker HE, Conyn-van Spaendonck MA. Immunosurveillance and the evaluation of national immunization programmes: a population-based approach. Epidemiol Infect. 1998;121(3):637-643. http://dx.doi.org/10.1017/S0950268898001587
18. van der Klis FR, Mollema L, Berbers GA, de Melker HE, Coutinho RA. Second national serum bank for population-based seroprevalence studies in the Netherlands. Neth J Med. 2009;67(7):301-308.
19. Conyn-Van Spaendonck MA, de Melker HE, Abbink F, Elzinga-Gholizadea N, Kimman TG, van Loon T. Immunity to poliomyelitis in The Netherlands. Am J Epidemiol. 2001;153(3):207-214. http://dx.doi.org/10.1093/aje/153.3.207
20. Mollema L, de Melker HE, Hahné SJ, Van Weert JW, Berbers G, Van der Klis FR. PIENTER 2-project: second research project on the protection against infectious diseases offered by the national immunization programme in the Netherlands. Bilthoven: National Institute for Public Health and the Environment; 2009. Report No.: 230421001. Available from: http://www.rivm.nl/dsresource?objectid=rivmp:11329&type=org&disposition=inline&ns_nc=1
21. World Health Organization (WHO). Guidelines for WHO/EPI collaborative studies on poliomyelitis: standard procedure for determining immunity to poliovirus using the microneutralization test. Geneva: WHO; 1993. Available from: http://apps.who.int/iris/bitstream/10665/70486/1/WHO_EPI_GEN_93.9_eng.pdf?ua=1
22. Robertson SE. The immunological basis for immunisation. Module 6. Poliomyelitis. Geneva: World Health Organization; 1993 WHO/EPI/GEN/9316. Available from: http://www.who.int/ihr/polio1993en.pdf
23. Ruijs WL, Hautvast JL, van Ansem WJ, Akkermans RP, van't Spijker K, Hulscher ME, et al. Measuring vaccination coverage in a hard to reach minority. Eur J Public Health. 2012;22(3):359-364. http://dx.doi.org/10.1093/eurpub/ckr081
24. Diedrich S, Claus H, Schreier E. Immunity status against poliomyelitis in Germany: determination of cut-off values in International Units. BMC Infect Dis. 2002;2:2. http://dx.doi.org/10.1186/1471-2334-2-2
25. Frantzidou F, Diza E, Halkia D, Antoniadis A. A seroprevalence study of poliovirus antibody in the population of northern Greece. Clin Microbiol Infect. 2005;11(1):68-71. http://dx.doi.org/10.1111/j.1469-0691.2004.00998.x
26. Nates SV, Martinez LC, Barril PA, Ferreyra LJ, Giordano MO, Masachessi G, et al. Long-lasting poliovirus-neutralizing antibodies among Argentinean population immunized with four or five oral polio vaccine doses 1 month to 19 years previously. Viral Immunol. 2007;20(1):3-10. http://dx.doi.org/10.1089/vim.2006.0071
27. Tafuri S, Prato R, Martinelli D, Calvario A, Bozzi A, Labianca M, et al. Serological survey on immunity status against polioviruses in children and adolescents living in a border region, Apulia (Southern Italy). BMC Infect Dis. 2008;8:150. http://dx.doi.org/10.1186/1471-2334-8-150
28. Li XM, Zhang HR, Wang YM. [Analysis of polio antibody levels in healthy population in Beijing in 2007]. Zhongguo Yi Miao He Mian Yi. 2009;15(3):245-248.
29. Abbink F, Buisman AM, Doornbos G, Woldman J, Kimman TG, Conyn-van Spaendonck MA. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion. J Infect Dis. 2005;191(6):990-999. http://dx.doi.org/10.1086/427810
30. Diedrich S, Schreier E. [The German Health Interview and Examination Survey for Children and Adolescents (KiGGS): state of immunity against poliomyelitis in German children]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007;50(5-6):771-774. German. http://dx.doi.org/10.1007/s00103-007-0239-1
31. Affanni P, Veronesi L, Rizziero S, Bizzoco S, Bracchi MT, Tanzi ML. Status of immunity against poliomyelitis: a study among European and extra-European young immigrants living in Parma. Acta Biomed. 2005;76(3):157-163.
32. Landelijk Coördinatiecentrum Reizigersadvisering (LCR). Vaccinaties. [Vaccinations]. Amsterdam: LCR. [Accessed Feb 2014]. Dutch. Available from: http://www.lcr.nl/Vaccinaties
33. Mollema L, Wijers N, Hahne SJ, van der Klis FR, Boshuizen HC, de Melker HE. Participation in and attitude towards the national immunization program in the Netherlands: data from population-based questionnaires. BMC Public Health. 2012;12:57. http://dx.doi.org/10.1186/1471-2458-12-57
34. Steens A, Mollema L, Berbers GA, van Gageldonk PG, van der Klis FR, de Melker HE. High tetanus antitoxin antibody concentrations in the Netherlands: a seroepidemiological study. Vaccine. 2010;28(49):7803-7809. http://dx.doi.org/10.1016/j.vaccine.2010.09.036
35. Wood DJ, Heath AB. Comparability of poliovirus neutralizing antibody tests. Biologicals. 1992;20(4):293-300. http://dx.doi.org/10.1016/S1045-1056(05)80050-8
36. Albrecht P, van Steenis G, van Wezel AL, Salk J. Standardization of poliovirus neutralizing antibody tests. Rev Infect Dis. 1984;6 Suppl 2:S540-S544. http://dx.doi.org/10.1093/clinids/6.Supplement_2.S540
37. Anderson RM, May RM, editors. Infectious diseases of humans: dynamics and control. New York Oxford University Press; 1991.
38. Ruijs WL, Hautvast JL, Van Ijzendoorn G, Van Ansem WJ, Van der Velden K, Hulscher ME. How orthodox protestant parents decide on the vaccination of their children: a qualitative study. BMC Public Health. 2012;12:408. http://dx.doi.org/10.1186/1471-2458-12-408
39. Ruijs WL, Hautvast JL, Van't Spijker K, Van der Velden K, Hulscher ME. Information on vaccination: meeting the needs of unvaccinated youngsters in the Netherlands. Eur J Public Health. 2011;21(3):344-346. http://dx.doi.org/10.1093/eurpub/ckq172